# Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides

> **NCT00751517** · PHASE2 · UNKNOWN · sponsor: **University of Parma**

## Conditions studied

- Wegener's Granulomatosis
- Churg-Strauss Syndrome
- Microscopic Polyangiitis
- Polyarteritis Nodosa

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT00751517
- **Lead sponsor:** University of Parma
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00751517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00751517, "Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00751517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*